ANPI: Summary for Angiotech Pharmaceuticals, Inc. - Yahoo! Canada Finance

	Sign In [New User? Sign Up]	Finance Home \|Help

Wednesday, February 10, 2010, 3:24am EST - Canadian Markets open in 6 hours and 6 minutes.

To create a watchlist or portfolio of shares, Sign-in or Register

Angiotech Pharmaceuticals, Inc. (ANPI)

On Feb 9: 1.03 USD 0.00 (0.00%)

MORE ON ANPI

Quotes

Summary

Charts

News & Info

Company

Analyst Coverage

Ownership

Financials

Angiotech Pharmaceuticals, Inc. (NasdaqNM:ANPI) Delayed quote data

Last Trade:	1.03 USD
Trade Time:	Feb 9
Change:	0.00 (0.00%)
Prev Close:	1.03
Open:	N/A
Bid:	N/A
Ask:	N/A
1y Target Est:	1.33

Day's Range:	N/A - N/A
52wk Range:	0.26 - 2.94
Volume:	0
Avg Vol (3m):	261,867
Market Cap:	N/A
P/E (ttm):	N/A
EPS (ttm):	N/A
Div & Yield:	N/A (N/A%)

1d 5d 3m 6m 1y 2y 5y max

Free Annual Reports

Add ANPI to Portfolio

Download Data

HEADLINES

•	ANGIOTECH PHARMACEUTICALS INC Financials
	EDGAR Online Financials (Sat, Feb 6)

•	Angiotech Pharmaceuticals Announces Conference Call and Webcast
	PRNewswire (Thu, Feb 4)

•	Angiotech Pharmaceuticals Announces Conference Call and Webcast
	CNW Group (Thu, Feb 4)

•	The Complete List of Canadian Stocks Traded on the Nasdaq
	at Seeking Alpha (Mon, Dec 21)

•	5 Top Stocks at Half Price
	at Motley Fool (Mon, Nov 16)

•	ANGIOTECH PHARMACEUTICALS INC Files SEC form 8-K, Results of Operations and Financial Condition
	EDGAR Online (Mon, Nov 9)

•	ANGIOTECH PHARMACEUTICALS INC Files SEC form 10-Q, Quarterly Report
	EDGAR Online (Mon, Nov 9)

•	Angiotech Pharmaceuticals Earnings Call scheduled for 11:00 am ET today
	CCBN (Mon, Nov 9)

•	ANGIOTECH PHARMACEUTICALS INC Files SEC form 8-K, Results of Operations and Financial Condition, Non-Reliance on Prev
	EDGAR Online (Thu, Oct 15)

•	5 Stocks Bouncing Back
	at Motley Fool (Thu, Oct 8)

•	3 Stocks Hitting High Notes
	at Motley Fool (Thu, Sep 24)

More Headlines for ANPI...

ANALYST

EPS Est (next year) (Dec-09) :	0.02
EPS Est (in 2 years) (Dec-10) :	0.14
Avg Rec (current)*:	4.0
PEG Ratio:	0.75

* (Strong Buy) 1.0 - 5.0 (Strong Sell)

Analyst Opinion - Estimates

BUSINESS SUMMARY

No business summary available for ANPI.

Add to Portfolio

Email to a Friend

•